Save time and get answers to complex questions with AI chat
Excipients list used in dexamethasone creams?Dabrafenib and trametinib cost?Mebendazole ingredients?Is guselkumab off patent in u s?Drug patent watch trametinib?
See the DrugPatentWatch profile for prasugrel
Prasugrel (brand name Effient) is used to prevent blood clots in people with acute coronary syndrome (ACS) who are planned to undergo percutaneous coronary intervention (PCI), such as receiving a coronary stent [1]. It works alongside aspirin as part of dual antiplatelet therapy [1].
Prasugrel is an antiplatelet medicine, meaning it helps stop platelets from sticking together to form clots. It targets the platelet P2Y12 receptor pathway, which is one reason it’s used after PCI in ACS patients to reduce the risk of stent-related and heart-attack-related clotting events [1].
The key use is tied to PCI in ACS patients. Since prasugrel’s role is to reduce clot risk around the time of stenting and after PCI, it generally isn’t the standard antiplatelet choice for people with coronary disease who are not being managed with PCI and dual therapy as indicated on the product’s labeling [1].
It is used with aspirin in the setting of ACS undergoing PCI. Patients should follow their prescriber’s instructions because prasugrel changes bleeding risk, and timing matters around procedures and surgery [1].
[1] https://www.drugpatentwatch.com/patent/effient-chemical-name-prasugrel-salt/patent/
Other Questions About Prasugrel :